Potency Determination Testing: Principles, Methods, and Laboratory Practice

Potency determination testing is a critical quality control procedure that quantifies the biological activity of pharmaceuticals, biologics, enzymes, and vitamins against certified reference standards. This technical article explains the principles, sample types, testing methods, regulatory standards, and practical applications of potency assays in accredited third-party laboratories and pharmaceutical manufacturing environments.

Technical Overview

Potency determination is a quantitative analytical experiment that measures the specific biological activity of a substance by comparing its effect on a biological system with that of a reference standard of known activity. Unlike chemical content assays, which measure the mass or concentration of an analyte, potency assays measure the functional capability of a molecule to produce a defined biological response. The result is typically expressed in international units (IU), USP units, units per milligram (U/mg), or units per milliliter (U/mL) rather than in mass percentages alone.

Potency testing is a core requirement in pharmacopoeial monographs worldwide, including the Chinese Pharmacopoeia (ChP), the United States Pharmacopeia (USP), and the European Pharmacopoeia (EP). For antibiotics, biologics, hormones, blood products, and enzyme preparations, regulatory authorities require potency data for batch release, stability evaluation, shelf-life assignment, and comparability studies. Because the measured response depends on living systems or biochemical interactions, potency experiments demand rigorous control of test organisms, incubation conditions, reference standard handling, and statistical evaluation of results.

Testing Samples

Antibiotic Substances and Formulations

Antibiotics such as penicillins, cephalosporins, aminoglycosides (streptomycin, gentamicin, neomycin), macrolides, and polymyxins are classic subjects of potency determination. Both active pharmaceutical ingredients (APIs) and finished dosage forms, including powders for injection, tablets, capsules, ophthalmic solutions, and topical creams, can be submitted for testing. Microbiological assays against standard indicator organisms remain the reference method for many of these products.

Biological Products and Biologics

Recombinant proteins, cytokines (interferons, interleukins, colony-stimulating factors), hormones (insulin, erythropoietin, human chorionic gonadotropin), monoclonal antibodies, and vaccines require cell-based or in-vivo potency assays. These products are often tested in lyophilized or liquid formulations, and their potency must be demonstrated relative to international or national standards.

Enzyme Preparations

Industrial and pharmaceutical enzyme preparations, including proteases, amylases, lipases, cellulases, and lysozyme, are characterized by their catalytic activity. Enzyme potency is expressed as activity units defined by the amount of substrate converted per unit time under specified conditions, following ISO, GB, or pharmacopoeial definitions.

Vitamins and Nutritional Products

Vitamins with pronounced biological activity profiles, such as vitamin B12, vitamin D, and biotin, may be evaluated by microbiological potency methods in which the growth of a vitamin-dependent microorganism is proportional to the vitamin content of the sample.

Reference Standards and Calibration Materials

Certified reference materials, working standards, and in-house standards used for method calibration and system suitability are also tested to verify their assigned potency values and to monitor stability during storage.

Testing Items

• Antimicrobial potency of antibiotic APIs and finished products (U/mg, IU/mg, or percentage of label claim)
• Enzyme activity determination (U/g, U/mL) for protease, amylase, lipase, and other enzyme preparations
• Cell-based biological potency of cytokines, hormones, and monoclonal antibodies (relative potency against a reference standard)
• Vitamin potency by microbiological assay (vitamin B12, folic acid, nicotinic acid, biotin)
• Heparin potency by chromogenic or clotting-based assays
• Antibody neutralization potency and virus-neutralizing antibody titers
• Potency confirmation of compounded or imported pharmaceutical preparations
• Potency monitoring in stability studies under ICH long-term and accelerated conditions

Testing Methods

Cylinder Plate Method (Agar Diffusion Assay)

The cylinder plate method, also known as the agar diffusion or cup-plate method, is the classical microbiological procedure described in ChP and USP <81> Antibiotics—Microbiological Assays. In this method, agar layers seeded with a susceptible test organism are inoculated with the sample, and stainless-steel cylinders or wells are placed on the surface. Solutions of the standard and the sample at multiple concentration levels are introduced into the cylinders. During incubation, the antibiotic diffuses into the agar and inhibits microbial growth, producing circular zones of inhibition whose diameters are proportional to the logarithm of the antibiotic concentration. Potency is calculated from the zone sizes using standard parallel-line or dose-response statistical models.

Turbidimetric Method

The turbidimetric method measures the inhibition of microbial growth in liquid medium. Identical tubes containing inoculated broth receive graded doses of the standard and sample. After incubation at a precisely controlled temperature, the optical density of each tube is measured spectrophotometrically. Because the degree of growth inhibition is related to antibiotic concentration, the potency of the sample can be calculated by comparing its response curve with that of the reference standard. This method is faster than agar diffusion and suitable for antibiotics that diffuse poorly in agar.

Cell-Based Bioassays

Biologics such as cytokines and therapeutic proteins are tested using cell proliferation assays, cytotoxicity assays, antiviral cytopathic effect reduction assays, or reporter gene assays. For example, interferon potency is determined by its ability to protect treated cells from virus-induced cytopathic effects, while interleukin potency is measured by stimulating the proliferation of a factor-dependent cell line. Results are calculated as relative potency using parallel-line analysis, and the method must demonstrate suitability for slope, symmetry, and linearity as required by USP <1032>, <1033>, and <1034> and ICH Q2(R2) validation guidance.

Chromogenic Substrate and Coagulation Assays

For products such as heparin and certain enzymes, potency is determined by synthetic chromogenic substrates that release a measurable chromophore upon enzymatic cleavage. The rate of color development, monitored at a defined wavelength, is proportional to the enzymatic or anticoagulant activity of the sample.

HPLC and Chromatographic Potency Methods

Where a validated correlation between chemical purity and biological activity exists, high-performance liquid chromatography (HPLC) methods may be used to determine potency. HPLC potency assays are increasingly adopted for antibiotics with well-characterized structures, offering improved precision, shorter analysis time, and reduced biological variability compared with microbiological methods.

Enzyme Activity Assays

Enzyme potency is determined by incubating the enzyme with an excess of its specific substrate under strictly controlled conditions of pH, temperature, and reaction time. The reaction product, such as reducing sugars, released chromophore, or tyrosine equivalents, is quantified photometrically, and one activity unit is defined as the amount of enzyme catalyzing the conversion of a defined quantity of substrate per minute.

Applications

• Batch release testing of antibiotic products for pharmaceutical manufacturers
• Quality control of biological products during upstream and downstream process development
• Stability studies and shelf-life determination for potency-labeled products
• Verification of imported drug substances and finished products against pharmacopoeial requirements
• Comparability exercises after process changes, scale-up, or site transfers
• Support for regulatory submissions requiring validated potency data under ICH guidelines
• Evaluation of industrial enzyme preparations for food, feed, detergent, and textile applications
• Research and development support for new biologics, biosimilars, and generic antibiotics
• Post-market surveillance and complaint investigation of potency-related quality defects

FAQ

What is the difference between potency and content?

Content refers to the quantity of a substance present in a sample, usually expressed as mass or percentage, while potency refers to the biological activity of that substance relative to a reference standard. A sample may have high chemical purity but reduced potency if the molecules are partially degraded or incorrectly folded.

Why are biological assay methods still used when HPLC is available?

For complex molecules such as antibiotics with multiple related components and for large biologics, chemical methods cannot fully predict biological function. Biological assays directly measure the therapeutic-relevant activity, which is why pharmacopoeias retain microbiological and cell-based potency methods even as chromatographic alternatives are developed for specific products.

What reference standards are used in potency determination?

Potency assays are performed against certified biological reference standards or chemical reference standards obtained from official pharmacopoeial authorities. Traceability to these standards ensures that results are comparable between laboratories and over time, which is essential for batch release and stability conclusions.

How are potency results statistically evaluated?

Microbiological and cell-based potency assays are evaluated using validated statistical models, typically parallel-line or sigmoidal dose-response analysis of log-transformed data. The assay is valid only when the standard and sample response curves are statistically parallel, regression is significant, and within the acceptance criteria for linearity and precision defined in the relevant pharmacopoeial chapter.

What sample volume and turnaround time should be expected?

Requirements vary by method and matrix. Microbiological agar diffusion and turbidimetric assays generally require one to two weeks including microbial propagation and assay incubation, while cell-based bioassays may require two to three weeks depending on cell culture growth curves. HPLC-based potency methods can often be completed within several working days. Accredited third-party laboratories confirm specific sample quantities, storage conditions, and schedules during the project consultation phase.